European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma

1. Zinzani, P.L.
2. Karlin, L.
3. Radford, J.
4. Caballero, D.
5. Fields, P.
6. Chamuleau, M.E.D.
7. D’Amore, F.
8. Haioun, C.
9. Thieblemont, C.
10. González-Barca, E.
11. Grande García, C.
12. Johnson, P.W.
13. Van Imhoff, G.W.
14. Ng, T.
15. Dwyer, K.
16. Morschhauser, F.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.3324/HAEMATOL.2016.146977 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus